CLDI logo

Calidi Biotherapeutics (CLDI) Company Overview

Profile

Full Name:

Calidi Biotherapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 1, 2021

Indexes:

Not included

Description:

Calidi Biotherapeutics (CLDI) focuses on developing innovative cancer treatments using oncolytic viruses. Their approach aims to target and destroy cancer cells while sparing healthy tissue, offering potential new therapies for patients. The company combines advanced science with a commitment to improving cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 15, 2024

Analyst ratings

Recent major analysts updates

Jun 27, 24 Ladenburg Thalmann
Buy
May 15, 24 Baird
Outperform
Mar 21, 24 HC Wainwright & Co.
Buy
Mar 21, 24 Baird
Outperform
Nov 22, 23 HC Wainwright & Co.
Buy
Oct 9, 23 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Calidi Biotherapeutics?
  • Does Calidi Biotherapeutics pay dividends?
  • What sector is Calidi Biotherapeutics in?
  • What industry is Calidi Biotherapeutics in?
  • What country is Calidi Biotherapeutics based in?
  • When did Calidi Biotherapeutics go public?
  • Is Calidi Biotherapeutics in the S&P 500?
  • Is Calidi Biotherapeutics in the NASDAQ 100?
  • Is Calidi Biotherapeutics in the Dow Jones?
  • When was Calidi Biotherapeutics's last earnings report?
  • When does Calidi Biotherapeutics report earnings?
  • Should I buy Calidi Biotherapeutics stock now?

What is the ticker symbol for Calidi Biotherapeutics?

The ticker symbol for Calidi Biotherapeutics is NYSE American:CLDI

Does Calidi Biotherapeutics pay dividends?

No, Calidi Biotherapeutics does not pay dividends

What sector is Calidi Biotherapeutics in?

Calidi Biotherapeutics is in the Healthcare sector

What industry is Calidi Biotherapeutics in?

Calidi Biotherapeutics is in the Biotechnology industry

What country is Calidi Biotherapeutics based in?

Calidi Biotherapeutics is headquartered in United States

When did Calidi Biotherapeutics go public?

Calidi Biotherapeutics's initial public offering (IPO) was on November 1, 2021

Is Calidi Biotherapeutics in the S&P 500?

No, Calidi Biotherapeutics is not included in the S&P 500 index

Is Calidi Biotherapeutics in the NASDAQ 100?

No, Calidi Biotherapeutics is not included in the NASDAQ 100 index

Is Calidi Biotherapeutics in the Dow Jones?

No, Calidi Biotherapeutics is not included in the Dow Jones index

When was Calidi Biotherapeutics's last earnings report?

Calidi Biotherapeutics's most recent earnings report was on Nov 12, 2024

When does Calidi Biotherapeutics report earnings?

The next expected earnings date for Calidi Biotherapeutics is Mar 14, 2025

Should I buy Calidi Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions